http://media.peerviewpress.com/000136/podcast/nuvis/xml/oncologyint_audio.xml Tue, 05 Jan 2010 11:48:19 -0500 NUVIS Group http://www.peerviewpress.com Podcast Maker v1.3 - http://www.lemonzdream.com/podcastmaker PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. Thought leader perspectives on current clinical advances in medicine. PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. 2008 PeerView Press, 42 Brook Street, Mayfair, London, W1K 5DB webmaster@peerviewpress.com http://podcast.peerviewpress.com/OncologyInternational/Oncology_international_album_art_QAAppr_140207_144.jpg http://www.peerviewpress.com 144 144 Science & Medicine PeerView Press, inSession, inReview, Oncology clean NUVIS Group The Impact of FGFR Inhibition on Breast Cancer and Other Solid Tumours Go online to www.peerviewpress.com/h/r98 to view the entire programme with slides. The Impact of FGFR Inhibition on Breast Cancer and Other Solid Tumours http://podcast.peerviewpress.com/OncologyInternational/ANINT06008r98.mp3 http://podcast.peerviewpress.com/OncologyInternational/ANINT06008r98.mp3 Thu, 24 Dec 2009 11:46:22 -0500 Science & Medicine no 00:09:27 fibroblast growth factor receptor inhibitor, FGFR, ligand, breast cancer, solid tumour, receptor tyrosine kinase, RTK, HER2, signalling, prostate, bladder, multiple myeloma, lymphoma, NSCLC, ovarian, hepatocellular, colorectal, TKI258 NUVIS Group New Data on EGFR-Inhibiting Agents for Non–Small-Cell Lung Cancer Go online to www.peerviewpress.com/h/r93 to view the entire programme with slides. New Data on EGFR-Inhibiting Agents for Non–Small-Cell Lung Cancer http://podcast.peerviewpress.com/OncologyInternational/ENUVI06009r93.mp3 http://podcast.peerviewpress.com/OncologyInternational/ENUVI06009r93.mp3 Tue, 08 Dec 2009 12:00:14 -0500 Science & Medicine no 00:19:59 non–small-cell lung cancer TKI kinase multikinase monoclonal targeted angiogenesis advanced relapsed NUVIS Group Case-Based Approach to Emerging 2009 GIST Management Go online to www.peerviewpress.com/h/p14 to view the entire programme with slides. Case-Based Approach to Emerging 2009 GIST Management http://podcast.peerviewpress.com/OncologyInternational/ENUVI05901p14.mp3 http://podcast.peerviewpress.com/OncologyInternational/ENUVI05901p14.mp3 Fri, 16 Oct 2009 14:59:47 -0400 Science & Medicine no 00:37:04 GIST, gastrointestinal stromal tumour, adjuvant, imatinib, sunitinib, size, location, mitotic rate, NCCN, ESMO, survival, ACOSOG NUVIS Group Improving Second-Line Treatment in Advanced Ovarian Cancer Go online to www.peerviewpress.com/h/s151 to view the entire programme with slides. Improving Second-Line Treatment in Advanced Ovarian Cancer http://podcast.peerviewpress.com/OncologyInternational/ANINT06277s151.mp3 http://podcast.peerviewpress.com/OncologyInternational/ANINT06277s151.mp3 Fri, 18 Sep 2009 11:53:12 -0400 Science & Medicine no 00:18:22 Ovarian cancer, advanced, recurring, chemotherapy, platinum-based, combination, carboplatin, PLD, pegylated, liposomal, doxorubicin, paclitaxel, CALYPSO NUVIS Group GIST: Evolving Treatment Algorithms to Optimise Care Go online to www.peerviewpress.com/h/s137 to view the entire programme with slides. GIST: Evolving Treatment Algorithms to Optimise Care http://podcast.peerviewpress.com/OncologyInternational/NI05786FCs137.mp3 http://podcast.peerviewpress.com/OncologyInternational/NI05786FCs137.mp3 Mon, 10 Aug 2009 10:14:19 -0400 Science & Medicine no 00:16:21 GIST, gastrointestinal stromal tumour, imatinib, adjuvant, neoadjuvant, advanced, metastatic, locally advanced, mitotic rate, Z9001, ESMO, NCCN, time to secondary resistance, BFR14 NUVIS Group New Developments in NSCLC: Extending the Benefit of First-Line Therapy Go online to www.peerviewpress.com/h/r463 to view the entire programme with slides. New Developments in NSCLC: Extending the Benefit of First-Line Therapy http://podcast.peerviewpress.com/OncologyInternational/NE05271FCr463.mp3 http://podcast.peerviewpress.com/OncologyInternational/NE05271FCr463.mp3 Thu, 23 Jul 2009 10:56:38 -0400 Science & Medicine no 00:22:39 lung cancer, non small cell lung cancer, bevacizumab, erlotinib, cetuximab, gefitinib, pemetrexed, maintenance therapy, EGFR, K-RAS or KRAS or kras NUVIS Group Adjuvant Therapy for GIST: Learning From the Present to Change the Future of Treatment Go online to www.peerviewpress.com/h/s552 to view the entire programme with slides. Adjuvant Therapy for GIST: Learning From the Present to Change the Future of Treatment http://podcast.peerviewpress.com/OncologyInternational/NI04797FCs552.mp3 http://podcast.peerviewpress.com/OncologyInternational/NI04797FCs552.mp3 Tue, 28 Apr 2009 11:59:26 -0400 Science & Medicine no 00:17:42 localised GIST, gastrointestinal stromal tumours, ACOSOG Z9001, imatinib, sunitinib, adjuvant, neoadjuvant, ESMO, NCCN, exon 11 mutation, reGISTry, SEER, surgical resection NUVIS Group Guidelines on the Prevention and Treatment of Cancer-Associated Thrombosis Go online to www.peerviewpress.com/h/r449 to view the entire programme with slides. Guidelines on the Prevention and Treatment of Cancer-Associated Thrombosis http://podcast.peerviewpress.com/OncologyInternational/NI05275FCr449.mp3 http://podcast.peerviewpress.com/OncologyInternational/NI05275FCr449.mp3 Fri, 13 Mar 2009 13:37:12 -0400 Science & Medicine no 00:49:40 VTE, venous thromboembolism, ASCO, ESMO, cancer, recurrent thromboembolism, thromboprophylaxis, surgery, pulmonary embolism, CANTHANOX, CLOT NUVIS Group Therapeutic Decisions in Second-Line NSCLC Go online to www.peerviewpress.com/h/p154 to view the entire programme with slides. Therapeutic Decisions in Second-Line NSCLC http://podcast.peerviewpress.com/OncologyInternational/NE05249FCp154.mp3 http://podcast.peerviewpress.com/OncologyInternational/NE05249FCp154.mp3 Thu, 12 Mar 2009 10:33:35 -0400 Science & Medicine no 00:15:21 Non–small-cell lung cancer, Tarceva, erlotinib, EGFR TKI, tyrosine kinase inhibitor, docetaxel, pemetrexed, squamous, neutropenia, adenocarcinoma, platinum failure, rash NUVIS Group Using Targeted Therapy to Improve Outcomes in Multiple Tumours Go online to www.peerviewpress.com/h/s528 to view the entire programme with slides. Using Targeted Therapy to Improve Outcomes in Multiple Tumours http://podcast.peerviewpress.com/OncologyInternational/NI04932FCs528.mp3 http://podcast.peerviewpress.com/OncologyInternational/NI04932FCs528.mp3 Fri, 20 Feb 2009 14:03:15 -0500 Science & Medicine no 00:26:41 mammalian target of rapamycin, mTOR inhibitors, neuroendocrine tumours, renal cell carcinoma, RCC, NET, RECORD-1, RAD001, everolimus, temsirolimus, deforolimus NUVIS Group Guidelines on the Prevention and Treatment of Cancer-Associated Thrombosis Go online to www.peerviewpress.com/h/s526 to view the entire programme with slides. Guidelines on the Prevention and Treatment of Cancer-Associated Thrombosis http://podcast.peerviewpress.com/OncologyInternational/NE05096FCs526.mp3 http://podcast.peerviewpress.com/OncologyInternational/NE05096FCs526.mp3 Mon, 02 Feb 2009 10:40:27 -0500 Science & Medicine no 00:38:35 VTE, venous thromboembolism, ASCO, ESMO, cancer, recurrent thromboembolism, thromboprophylaxis, surgery, pulmonary embolism, CANTHANOX, CLOT NUVIS Group Case-Based Approach to Emerging 2008 GIST Management Go online to www.peerviewpress.com/h/p137 to view the entire programme with slides. Case-Based Approach to Emerging 2008 GIST Management http://podcast.peerviewpress.com/OncologyInternational/NI04141p137.mp3 http://podcast.peerviewpress.com/OncologyInternational/NI04141FCp137.mp3 Tue, 09 Dec 2008 11:26:55 -0500 Science & Medicine no 00:39:26 GIST, adjuvant, imatinib, sunitinib, size, location, mitotic rate, NCCN, ESM NUVIS Group Evidence-Based Decisions in the Management of Advanced Prostate Cancer Go online to www.peerviewpress.com/h/r419 to view the entire programme with slides. Evidence-Based Decisions in the Management of Advanced Prostate Cancer http://podcast.peerviewpress.com/OncologyInternational/NE04518FCr419.mp3 http://podcast.peerviewpress.com/OncologyInternational/NE04518FCr419.mp3 Thu, 23 Oct 2008 11:26:55 -0400 Science & Medicine no 00:25:22 HRPC, chemotherapy, urologists, oncologists, prostate cancer, PSA, seniors, metastasis, advanced prostate cancer, systemic therapy, minimal pain HRPC, elderly NUVIS Group Update on GIST Treatment Strategies: What the Latest Evidence Indicates Go online to www.peerviewpress.com/h/s478 to view the entire programme with slides. Update on GIST Treatment Strategies: What the Latest Evidence Indicates http://podcast.peerviewpress.com/OncologyInternational/NI04796s478.mp3 http://podcast.peerviewpress.com/OncologyInternational/NI04796FCs478.mp3 Tue, 02 Sep 2008 11:27:18 -0400 Science & Medicine no 00:18:31 GIST, gastrointestinal stromal tumours, adjuvant, B2222, ACOSOG Z9000, Z9001, plasma level, trough, imatinib, mutation status, KIT, PDGFR, platelet-derived growth factor receptor, exon 11, exon 9, Cmin, quartile, ESMO, European Society of Medical Oncology NUVIS Group Antitumour Activity of Bisphosphonates: Myth or Reality? Go online to www.peerviewpress.com/h/r406 to view the entire programme with slides. Antitumour Activity of Bisphosphonates: Myth or Reality? http://podcast.peerviewpress.com/OncologyInternational/NI04887FCr406.mp3 http://podcast.peerviewpress.com/OncologyInternational/NI04887FCr406.mp3 Thu, 05 Jun 2008 10:57:42 -0400 Science & Medicine no 00:08:19 zoledronic acid, bisphosphonates, antitumour activity, osteoblasts, osteoclasts, FPP synthase, tumour cell growth NUVIS Group Pathways of Innovation in Oncology: Improving Patient Outcomes in the Treatment of Renal Cell Carcinoma Go online to www.peerviewpress.com/h/r376 to view the entire programme with slides. Pathways of Innovation in Oncology: Improving Patient Outcomes in the Treatment of Renal Cell Carcinoma http://podcast.peerviewpress.com/OncologyInternational/NI04660FCr376.mp3 http://podcast.peerviewpress.com/OncologyInternational/NI04660FCr376.mp3 Wed, 21 May 2008 14:28:25 -0400 Science & Medicine no 00:17:25 PeerView Press, inSession, inReview, Oncology NUVIS Group Exploring the Anthracycline Controversy in Breast Cancer: What Does the Evidence Tell Us? Go online to www.peerviewpress.com/h/s466 to view the entire programme with slides. Exploring the Anthracycline Controversy in Breast Cancer: What Does the Evidence Tell Us? http://podcast.peerviewpress.com/OncologyInternational/NE04167FCs466.mp3 http://podcast.peerviewpress.com/OncologyInternational/NE04167FCs466.mp3 Thu, 08 May 2008 14:28:34 -0400 Science & Medicine no 00:34:15 anthracycline, nonanthracycline, taxane, docetaxel, HER2, hormone receptor, dose-dense, gene signature, NSABP B-30, NSABP B-38, 06090, MINDACT, amplification NUVIS Group Recent Data on First-Line Treatment Options for NSCLC: Implications for Clinical Practice Go online to www.peerviewpress.com/h/r397 to view the entire programme with slides. Recent Data on First-Line Treatment Options for NSCLC: Implications for Clinical Practice http://podcast.peerviewpress.com/OncologyInternational/NE04164FCr397.mp3 http://podcast.peerviewpress.com/OncologyInternational/NE04164FCr397.mp3 Fri, 25 Apr 2008 10:07:01 -0400 Science & Medicine no 00:31:22 docetaxel, bevacizumab, cetuximab, paclitaxel, vinorelbine, vinca alkaloid, non-small-cell lung cancer, lung cancer, NSCLC NUVIS Group Update on Second-Line Treatment Options in Advanced NSCLC: Cytotoxic and Targeted Therapies Go online to www.peerviewpress.com/h/r385 to view the entire programme with slides. Update on Second-Line Treatment Options in Advanced NSCLC: Cytotoxic and Targeted Therapies http://podcast.peerviewpress.com/OncologyInternational/NE04571FCr385.mp3 http://podcast.peerviewpress.com/OncologyInternational/NE04571FCr385.mp3 Fri, 22 Feb 2008 17:06:28 -0500 Science & Medicine no yes 00:26:03 NSCLC, non-small-cell lung cancer, Tarceva, erlotinib, gefitinib, EGFR TKI, tyrosine kinase inhibitor NUVIS Group Biologic Agents Targeting Multiple Receptors for the Treatment of Non–Small-Cell Lung Cancer (NSCLC) Go online to www.peerviewpress.com/h/s342 to view the entire programme with slides. Biologic Agents Targeting Multiple Receptors for the Treatment of Non–Small-Cell Lung Cancer (NSCLC) http://podcast.peerviewpress.com/OncologyInternational/NEO3840FCr342.mp3 http://podcast.peerviewpress.com/OncologyInternational/NE03840FCr342.mp3 Wed, 12 Dec 2007 13:13:45 -0500 Science & Medicine no 00:16:06 Vandetanib, epidermal growth factor receptor, vascular endothelial growth factor, sorafenib, sunitinib, vatalanib NUVIS Group Treatment of Solid Tumours: Update From ECCO Go online to www.peerviewpress.com/h/s456 to view the entire programme with slides. Treatment of Solid Tumours: Update From ECCO http://podcast.peerviewpress.com/OncologyInternational/NI04226FCs456.mp3 http://podcast.peerviewpress.com/OncologyInternational/NI04226FCs456_2.mp3 Wed, 21 Nov 2007 09:35:36 -0500 Science & Medicine no 00:36:53 Metastatic breast cancer, breast cancer, lung cancer, NSCLC, taxane, paclitaxel, nab-paclitaxel, protein-bound paclitaxel, albumin-bound paclitaxel, ECCO, peripheral neuropathy, Cremophor, adjuvant chemotherapy, neoadjuvant chemotherapy NUVIS Group Improving Survival in Early and Metastatic Breast Cancer Go online to www.peerviewpress.com/h/r333 to view the entire programme with slides. Improving Survival in Early and Metastatic Breast Cancer http://podcast.peerviewpress.com/OncologyInternational/NI04052FCr333.mp3 http://podcast.peerviewpress.com/OncologyInternational/NI04052FCr333.mp3 Tue, 28 Aug 2007 15:47:49 -0400 Science & Medicine no 00:34:03 Breast cancer, letrozole, anastrozole, aromatase inhibitors, tamoxifen, bisphosphonates, zoledronic acid, pamidronate, ibandronate, clodronate, skeletal-related events, SRE, AI, distant disease-free survival, NTX, bone markers NUVIS Group 7-Year Follow-Up of R-CHOP Chemotherapy for Diffuse Large B-Cell Lymphoma Go online to www.peerviewpress.com/h/s425 to view the entire programme with slides. 7-Year Follow-Up of R-CHOP Chemotherapy for Diffuse Large B-Cell Lymphoma http://podcast.peerviewpress.com/OncologyInternational/NE04075FCs425.mp3 http://podcast.peerviewpress.com/OncologyInternational/NE04075FCs425.mp3 Fri, 27 Jul 2007 16:31:00 -0400 Science & Medicine no 00:07:51 Rituximab, NHL, non-hodgkin’s lymphoma, lymphoma, CHOP, R-CHOP, diffuse large B-cell lymphoma, antibody, anti-CD20, survival, progression-free survival, event-free survival, overall survival NUVIS Group Targeted Therapy in Gastrointestinal Stromal Tumours (GIST) Go online to www.peerviewpress.com/h/s398 to view the entire programme with slides. Targeted Therapy in Gastrointestinal Stromal Tumours (GIST) http://podcast.peerviewpress.com/OncologyInternational/NI03929FCs398.mp3 http://podcast.peerviewpress.com/OncologyInternational/NI03929FCs398.mp3 Fri, 13 Jul 2007 16:15:06 -0400 Science & Medicine no 00:34:27 American College of Surgeons,Oncology Group (ACOSOG),American Society of Clinical Oncology (ASCO), annual meeting,French Sarcoma Group,Gastrointestinal stromal tumour (GIST),Imatinib,KIT mutation,MetaGIST Program,Sunitinib,Tumour bulk NUVIS Group Current and Novel Treatment Approaches for Head and Neck Cancer Go online to www.peerviewpress.com/h/s306 to view the entire programme with slides. Current and Novel Treatment Approaches for Head and Neck Cancer http://podcast.peerviewpress.com/OncologyInternational/NE03659FCs306.mp3 http://podcast.peerviewpress.com/OncologyInternational/NE03659FCs306.mp3 Fri, 22 Jun 2007 12:21:44 -0400 Science & Medicine no 00:36:40 Head and neck cancer, HNC, squamous cell carcinoma of the head and neck, SCCHN, epidermal growth factor receptor, EGFR, lapatinib, Tykerb, cetuximab, erlotinib, ESTRO NUVIS Group Update on the Use of Targeted Therapy in Patients With Advanced Pancreatic Cancer Go online to www.peerviewpress.com/h/r311 to view the entire programme with slides. Update on the Use of Targeted Therapy in Patients With Advanced Pancreatic Cancer http://podcast.peerviewpress.com/OncologyInternational/NE03940FCr311.mp3 http://podcast.peerviewpress.com/OncologyInternational/NE03940FCr311.mp3 Tue, 12 Jun 2007 16:01:56 -0400 Science & Medicine no 00:28:09 Pancreatic cancer, erlotinib, gemcitabine, rash, EGFR, epidermal growth factor receptor, K-ras, PA.3 trial, tyrosine kinase inhibitors, bevacizumab, capecitabine, targeted therapy, prognosis, mortality, epidemiology, incidence, prevalence, staging NUVIS Group Go online to www.peerviewpress.com/h/s370 to view the entire programme with slides. Go online to www.peerviewpress.com/h/s370 to view the entire programme with slides. Go online to www.peerviewpress.com/h/s370 to view the entire programme with slides. http://podcast.peerviewpress.com/OncologyInternational/NE03839FCs370.mp3 http://podcast.peerviewpress.com/OncologyInternational/NE03839FCs370.mp3 Fri, 08 Jun 2007 13:40:05 -0400 Science & Medicine no 00:37:20 Breast cancer, HER2, ErbB, lapatinib, Tykerb, trastuzumab, Herceptin, ALTTO, neo-ALTTO, TEACH, early stage, 10th International St.Gallen Oncology Conference, SGOC NUVIS Group Go online to www.peerviewpress.com/h/r304 to view the entire programme with slides. Go online to www.peerviewpress.com/h/r304 to view the entire programme with slides. Go online to www.peerviewpress.com/h/r304 to view the entire programme with slides. http://podcast.peerviewpress.com/OncologyInternational/NI03835FCr304.mp3 http://podcast.peerviewpress.com/OncologyInternational/NI03835FCr304.mp3 Mon, 14 May 2007 16:36:16 -0400 Science & Medicine no 00:31:38 Angiogenesis,Astrocytoma,Bevacizumab,Brain,tumour.Carmustine,waferEpidermal,growth,factor,receptor,(EGFR)Glioblastoma,multiformeGliomaHistone,deacetylase,(HDAC)HydroxyureaImatinibIrinotecanPlatelet-derived,growth,factor,receptor,(PDGFR) NUVIS Group Go online to www.peerviewpress.com/h/s395 to view the entire programme with slides. Go online to www.peerviewpress.com/h/s395 to view the entire programme with slides. Go online to www.peerviewpress.com/h/s395 to view the entire programme with slides. http://podcast.peerviewpress.com/OncologyInternational/NI03894FCs395.mp3 http://podcast.peerviewpress.com/OncologyInternational/NI03894FCs395.mp3 Fri, 11 May 2007 16:18:15 -0400 Science & Medicine no 00:19:50 Aromatase inhibitors, breast cancer, adjuvant treatment, early recurrence, distant metastasis, distant metastases, distant recurrence, distant disease free survival, DDFS, endpoints, letrozole, Femara, anastrozole, Arimidex, SGOC NUVIS Group Specific, targeted molecules are designed to inhibit gene-translocation products, such as those found in Philadelphia chromosome–positive acute lymphoblastic leukaemia, atypical myeloproliferative disorders, and dermatofibrosarcoma protuberans. Internationally-recognised experts discuss the latest efficacy and safety data concerning the use of targeted agents in these rare cancers. Go online to www.peerviewpress.com/h/r303 to view the entire programme with slides. Specific, targeted molecules are designed to inhibit gene-translocation products, such as those found in Philadelphia chromosome–positive acute lymphoblastic leukaemia, atypical myeloproliferative disorders, and dermatofibrosarcoma protuberans. Internationally-recognised experts discuss the latest efficacy and safety data concerning the use of targeted agents in these rare cancers. http://podcast.peerviewpress.com/OncologyInternational/NI03838FCr303.mp3 http://podcast.peerviewpress.com/OncologyInternational/NI03838FCr303.mp3 Fri, 16 Mar 2007 16:14:01 -0400 Science & Medicine no 00:32:01 acute lymphoblastic leukaemia (ALL),alemtuzumab myeloproliferative disorder,atypical Campath,chronic eosinophilic leukaemia,chronic myelogenous leukaemia (CML),dasatinib dermatofibrosarcoma protuberans (DFSP),Gleevec,Glivec NUVIS Group A Clinical Update on Aromatase Inhibitors as Adjuvant Therapy in Breast Cancer Go online to www.peerviewpress.com/h/s356 to view the entire programme with slides. A Clinical Update on Aromatase Inhibitors as Adjuvant Therapy in Breast Cancer http://podcast.peerviewpress.com/OncologyInternational/NI03782FCs356.mp3 http://podcast.peerviewpress.com/OncologyInternational/NI03782FCs356.mp3 Fri, 23 Feb 2007 16:30:06 -0500 Science & Medicine no 00:19:41 juvant endocrine therapy, early-stage breast cancer, aromatase inhibitors, letrozole, anastrozole, exemestane, tamoxifen, BIG 1-98, ATAC, NSABP B-33, MA.17 NUVIS Group Advances in the Treatment of Breast Cancer: Targeting the ErbB and VEGF Pathways Go online to www.peerviewpress.com/h/s312 to view the entire programme with slides. Advances in the Treatment of Breast Cancer: Targeting the ErbB and VEGF Pathways http://podcast.peerviewpress.com/OncologyInternational/NE03660FCs312.mp3 http://podcast.peerviewpress.com/OncologyInternational/NE03660FCs312.mp3 Thu, 15 Feb 2007 15:42:58 -0500 Science & Medicine no 00:48:56 Breast cancer, HER2, ErbB, VEGF, lapatinib, Tykerb, trastuzumab, Herceptin, cardiotoxicity NUVIS Group Advances in the Treatment of Breast Cancer: Targeting the ErbB and VEGF Pathways Go online to www.peerviewpress.com/h/s307 to view the entire programme with slides. Advances in the Treatment of Breast Cancer: Targeting the ErbB and VEGF Pathways http://podcast.peerviewpress.com/OncologyInternational/NE03660FCs307.mp3 http://podcast.peerviewpress.com/OncologyInternational/NE03660FCs307.mp3 Thu, 15 Feb 2007 15:39:29 -0500 Science & Medicine no 00:48:56 Breast cancer, HER2, ErbB, VEGF, lapatinib, Tykerb, trastuzumab, Herceptin, cardiotoxicity